1. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997. 337:734–739.
Article
2. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001. 158:725–730.
Article
3. Lee C, Kang MW, Kim JJ, Lee CU, Lee SJ, Paik IH. Psychosocial variables in HIV-positive patients. J Korean Neuropsychiatr Assoc. 2001. 40:1055–1061.
4. Lee SH, Koh KB, Kim JM, Hong SK, Choi TK, Lee EH, Suh SY. Psychosocial factors associated with biological markers in Korean patients with human immunodeficiency virus infection. J Korean Neuropsychiatr Assoc. 2006. 45:34–41.
5. Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr. 2006. 43:Suppl 1. S149–S155.
6. Halkitis PN, Shrem MT, Zade DD, Wilton L. The physical, emotional and interpersonal impact of HAART: exploring the realities of HIV seropositive individuals on combination therapy. J Health Psychol. 2005. 10:345–358.
Article